USA: 
Europe: 
Email: 
Consultation
| Catalog: | C-MD-0012T |
| Product Type: | Test kit |
| Unit: | 46 tests |
| Tested parameter: | BCR-ABL p210 |
| Assay time: | 2 h |
| Sample type: | Bone marrow or peripheral blood |
| Test type: | Quantitative |
| Analysis mode: | Real-time PCR |
| Application: | Lymphoma and leukemia |
This kit is used to quantitatively detect BCR-ABL p210 b2a2 and b3a2 fusion transcripts in bone marrow or peripheral blood samples of patients diagnosed with acute lymphoblastic leukemia (ALL) or chronic myeloid leukemia (CML) by real-time PCR. It can be used to monitor minimal residual disease (MRD) in patients undergoing treatment.
Core Diagnostic Capabilities
Follow Us -
Copyright © 2024 Creative Biogene. All rights reserved.
